➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Mallinckrodt
Baxter
Boehringer Ingelheim
McKesson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

RIFABUTIN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for rifabutin and what is the scope of freedom to operate?

Rifabutin is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn and Lupin Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for rifabutin. Four suppliers are listed for this compound.

Drug Prices for RIFABUTIN

See drug prices for RIFABUTIN

Recent Clinical Trials for RIFABUTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BeiGenePhase 1
Cystic Fibrosis FoundationPhase 2/Phase 3
South Australian Health and Medical Research InstitutePhase 2/Phase 3

See all RIFABUTIN clinical trials

Pharmacology for RIFABUTIN
Medical Subject Heading (MeSH) Categories for RIFABUTIN

US Patents and Regulatory Information for RIFABUTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn MYCOBUTIN rifabutin CAPSULE;ORAL 050689-001 Dec 23, 1992 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Lupin Ltd RIFABUTIN rifabutin CAPSULE;ORAL 090033-001 Feb 24, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Harvard Business School
AstraZeneca
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.